Biochemical Pharmacology volume 80, issue 10, P1507-1516 2010 DOI: 10.1016/j.bcp.2010.08.002 View full text
|
|
Share
Anna Eriksson, Martin Höglund, Elin Lindhagen, Anna Åleskog, Sadia Bashir Hassan, Carina Ekholm, Karin Fhölenhag, Annika Jenmalm Jensen, Agneta Löthgren, Martin Scobie, Rolf Larsson, Vendela Parrow

Abstract: AbstractAberrant signal transduction by mutant or overexpressed protein kinases has emerged as a promising target for treatment of acute myeloid leukemia (AML). We here present a novel low